WO2009053256A3 - Process for the production of beta lactam crystals - Google Patents
Process for the production of beta lactam crystals Download PDFInfo
- Publication number
- WO2009053256A3 WO2009053256A3 PCT/EP2008/063604 EP2008063604W WO2009053256A3 WO 2009053256 A3 WO2009053256 A3 WO 2009053256A3 EP 2008063604 W EP2008063604 W EP 2008063604W WO 2009053256 A3 WO2009053256 A3 WO 2009053256A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- production
- beta lactam
- crystals
- lactam crystals
- giving
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/04—Preparation
- C07D499/14—Preparation of salts
- C07D499/16—Preparation of salts of alkali or alkaline earth metals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
An improved process for the production of Sulbactam Sodium characterised in that aqueous Isopropyl Alcohol is used as crystallisation medium. The crystals thus obtained can be smoothly dried, giving a content of residual solvent lower than 0.1%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07118997 | 2007-10-22 | ||
EP07118997.1 | 2007-10-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009053256A2 WO2009053256A2 (en) | 2009-04-30 |
WO2009053256A3 true WO2009053256A3 (en) | 2009-07-09 |
Family
ID=39272408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/063604 WO2009053256A2 (en) | 2007-10-22 | 2008-10-10 | Process for the production of beta lactam crystals |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009053256A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103113390B (en) * | 2013-03-12 | 2014-10-08 | 四川省惠达药业有限公司 | Sulbactam sodium compound and medical composition of sulbactam sodium compound and mezlocillin sodium |
CN103127114B (en) * | 2013-03-12 | 2014-02-26 | 四川省惠达药业有限公司 | Medicinal composition including piperacillin sodium and sulbactam sodium |
CN104876946A (en) * | 2015-04-30 | 2015-09-02 | 王雪雁 | Sulbactam compound for treating infectious diseases, and preparation method therefor |
CN104958318A (en) * | 2015-08-04 | 2015-10-07 | 青岛蓝盛洋医药生物科技有限责任公司 | Medicinal sulbactam sodium composition for treating infectious diseases |
CN111233893A (en) * | 2020-03-13 | 2020-06-05 | 山东二叶制药有限公司 | Preparation process of sulbactam sodium |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2461949A (en) * | 1944-06-13 | 1949-02-15 | Squibb & Sons Inc | Method of obtaining a crystalline sodium penicillin |
US4234579A (en) * | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
PL163690B1 (en) * | 1990-07-02 | 1994-04-29 | Inst Farmaceutyczny | Method of obtaining sodium salt of penicillanic acid 1,1-dioxide |
-
2008
- 2008-10-10 WO PCT/EP2008/063604 patent/WO2009053256A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2461949A (en) * | 1944-06-13 | 1949-02-15 | Squibb & Sons Inc | Method of obtaining a crystalline sodium penicillin |
US4234579A (en) * | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
PL163690B1 (en) * | 1990-07-02 | 1994-04-29 | Inst Farmaceutyczny | Method of obtaining sodium salt of penicillanic acid 1,1-dioxide |
Non-Patent Citations (10)
Title |
---|
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1 April 1998 (1998-04-01), XP002476497, retrieved from STN Database accession no. 128:257257(DN) * |
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 12 October 2006 (2006-10-12), XP002476499, retrieved from STN Database accession no. 146:487109(DN) * |
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 15 July 1995 (1995-07-15), XP002476498, retrieved from STN Database accession no. 123:55588(DN) * |
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 28 February 2007 (2007-02-28), XP002476501, retrieved from STN Database accession no. 148:191748(DN) * |
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 5 April 1987 (1987-04-05), XP002476500, retrieved from STN Database accession no. 106:101926(DN) * |
LIST, P.H., HÖRHAMMER, L., EDITORS: "HAGERS HANDBUCH DER PHARMAZEUTISCHEN PRAXIS", 1971, SPRINGER-VERLAG, BERLIN, XP002476496 * |
LU, YE ET AL: "IMPROVEMENT OF CRYSTALIZATION OF SULBACTAM SODIUM", HEILONGJIANG YIYAO, vol. 19, no. 3, 2006, pages 185 - 186, XP008090259 * |
QIU, FANG-LI ET AL, HUAXUE SHIJIE, vol. 47, no. 2, 2006, pages 99 - 101, XP008090122 * |
VLASE CRISTINA ET AL, REVISTA DE CHIMIE, BUCHAREST, RO, vol. 49, no. 2, 1998, pages 96 - 101, XP008090123, ISSN: 0034-7752 * |
YOU, JINYING ET AL, KANGSHENGSU, vol. 11, no. 4, 1986, pages 363 - 365, XP008090204 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009053256A2 (en) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007035629A3 (en) | Process for the preparation of pyrimidinedione derivatives | |
WO2010003078A3 (en) | Melt granulation process | |
WO2009046696A3 (en) | Material system and method for changing properties of a plastic component | |
WO2011006896A3 (en) | A process for preparing an aqueous suspension of an organic pesticide compound | |
WO2009053256A3 (en) | Process for the production of beta lactam crystals | |
WO2007060448A3 (en) | Chemical process for the preparation of an amido-phenoxybenzoic acid compound | |
IL182309A0 (en) | Non-reclosable packaging for products prejudicial to health, as well as process for its production | |
WO2008116107A3 (en) | Piperazine derivatives as glucokinase activators | |
WO2008079787A8 (en) | Glucokinase activators | |
WO2008023027A3 (en) | Process for preparing pramipexole dihydrochloride tablets with high storage stability | |
WO2009036281A3 (en) | Bortezomib and process for producing same | |
WO2007041269A3 (en) | Fermentive production of four carbon alcohols | |
WO2007077580A3 (en) | Improved process for pure duloxetine hydrochloride | |
AU2010333959A8 (en) | Organically chelated mineral compositions and methods thereof | |
MX2009003257A (en) | Process for synthesis of phenoxy diaminopyrimidine derivatives. | |
EP1582514A4 (en) | Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production | |
WO2007115210A3 (en) | Non-starchy rice bran polysaccharides | |
WO2009130604A3 (en) | Solid state forms of deferasirox salts and process for the preparation thereof | |
PH12014501559A1 (en) | Carrageenan modified by ion-exchange process | |
WO2009092702A3 (en) | ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production employing a 2-deoxyribose-5-phosphate aldolase | |
WO2010064109A3 (en) | An improved process for the preparation of montelukast sodium and its intermediates | |
WO2007017895A3 (en) | Stabilized oral pharmaceutical compositions of cephalosporins | |
WO2007013043A3 (en) | Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid | |
WO2009149053A3 (en) | Naproxcinod process and solid dispersion | |
EP2025663A4 (en) | Novel carboxylic acid compound, use thereof, and process for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08805216 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08805216 Country of ref document: EP Kind code of ref document: A2 |